Treatment of the FAS expressing MM cell lines U266 and RPMI8226 with the FAS inhibitor cerulenin resulted in induction of apoptosis evidenced by increased Annexin V staining suggesting FAS as a possible target of anti-myeloma therapy. This evidence concerns the gene ANXA5 and Miyoshi myopathy.